SEC Tracker
Get the app

X4 Pharmaceuticals XFOR

X4 Pharmaceuticals: reports quarterly results and makes a Regulation FD disclosure

Form
8-K
Filed
Importance
Routine
  • Reports quarterly results (2.02)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when X4 Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. Artiva Biotherapeutics ARTV public float $15M, Jun 30, 2025
  2. Pluri PLUR public float $15M, Dec 31, 2025
  3. NKGen Biotech NKGN public float $14M, Jun 30, 2025
  4. Kalaris Therapeutics KLRS public float $13M, Jun 30, 2025
  5. Cognition Therapeutics CGTX public float $18M, Jun 30, 2025